ArticleJournal of medicinal chemistry2018

Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening.

Samuel H Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.